Cargando…

Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial)

BACKGROUND: Sentinel lymph node (SLN) mapping has been recommended as an alternative staging approach to lymphadenectomy for apparent uterine-confined endometrial cancer (EC). However, the prognostic value of SLN mapping alone instead of systematic lymphadenectomy on EC patients remains unclear. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guan, Jun, Xue, Yu, Zang, Rong-yu, Liu, Ji-hong, Zhu, Jian-qing, Zheng, Ying, Wang, Bo, Wang, Hua-ying, Chen, Xiao-jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Materias:	Clinical Trial Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192227/ https://www.ncbi.nlm.nih.gov/pubmed/34085796 http://dx.doi.org/10.3802/jgo.2021.32.e60

Ejemplares similares

Lymphatic Complications Following Sentinel Node Biopsy or Pelvic Lymphadenectomy for Endometrial Cancer
por: Terada, Shinichi, et al.
Publicado: (2023)

Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
Publicado: (2009)

Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging
por: Cusimano, Maria C., et al.
Publicado: (2020)

Avoiding Full Lymphadenectomies in Intermediate- and High-Risk Endometrial Cancer by Sentinel Lymph Node Biopsy Implementation
por: Pineda, Virginia García, et al.
Publicado: (2021)

Beyond Sentinel Lymph Node: Outcomes of Indocyanine Green-Guided Pelvic Lymphadenectomy in Endometrial and Cervical Cancer
por: Chiofalo, Benito, et al.
Publicado: (2023)

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer
por: van den Heerik, Anne Sophie V M, et al.
Publicado: (2020)

Operative and Oncological Outcomes Comparing Sentinel Node Mapping and Systematic Lymphadenectomy in Endometrial Cancer Staging: Meta-Analysis With Trial Sequential Analysis
por: Gu, Yu, et al.
Publicado: (2021)

A prospective randomized multicenter trial for lymphadenectomy in early-stage ovarian cancer: LOVE study
por: Deng, Ting, et al.
Publicado: (2023)

The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
por: de Boniface, Jana, et al.
Publicado: (2020)

Open Surgery including Lymphadenectomy without Adjuvant Therapy for Uterine-Confined Intermediate- and High-Risk Endometrioid Endometrial Carcinoma
por: Otsuka, Isao, et al.
Publicado: (2022)

Survival benefits of pelvic lymphadenectomy versus pelvic and para-aortic lymphadenectomy in patients with endometrial cancer: A meta-analysis
por: Guo, Weina, et al.
Publicado: (2018)

Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT)
por: Li, Yang, et al.
Publicado: (2023)

Complications after open and laparoscopic right-sided colectomy with central lymphadenectomy for colon cancer: randomized controlled trial
por: Lygre, Kristin B, et al.
Publicado: (2023)

Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer
por: Andersson, Y., et al.
Publicado: (2019)

Survival analysis of pelvic lymphadenectomy alone versus combined pelvic and para-aortic lymphadenectomy in patients exhibiting endometrioid type endometrial cancer
por: TOPTAS, TAYFUN, et al.
Publicado: (2015)

Ultra‐hypofractionated radiation therapy for unfavourable intermediate‐risk and high‐risk prostate cancer is safe and effective: 5‐year outcomes of a phase II trial
por: Macias, Victor A., et al.
Publicado: (2019)

Self Nano-Emulsifying Curcumin (SNEC30) attenuates arsenic-induced cell death in mice
por: Jamal, Zarqua, et al.
Publicado: (2021)

A multicenter noninferior randomized controlled study of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus lymphadenectomy for patients with stage I endometrial cancer, INSEC trial concept
por: Guo, Yanglong, et al.
Publicado: (2023)

Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program
Publicado: (2023)

Intraoperative frozen pathology exam of Common iliac lymph nodes and Para-Aortic lymphadenectomy on the prognosis and quality of life for patients with IB2-IIA2 Cervical Cancer: trial protocol for a randomized controlled trial (C-PACC trial)
por: Qu, Xinyu, et al.
Publicado: (2022)

Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer
por: Zetterlund, Linda, et al.
Publicado: (2017)

Role of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study
por: Coronado, Pluvio J., et al.
Publicado: (2018)

Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer
por: Zetterlund, Linda Holmstrand, et al.
Publicado: (2017)

Comparison of the effect of the pelvic floor muscle biofeedback prior or postradical prostatectomy on urinary incontinence: A randomized controlled trial
por: Allameh, Farzad, et al.
Publicado: (2022)

The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer
por: Thomas, J. S., et al.
Publicado: (2017)

Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus
por: Kasamatsu, T, et al.
Publicado: (2003)

Systematic lymphadenectomy for intermediate risk endometrial carcinoma treatment does not improve the oncological outcome
por: Candido, Elaine C., et al.
Publicado: (2019)

Role of systematic lymphadenectomy in patients with intermediate to high-risk early stage endometrial cancer
por: Kim, Nae Ry, et al.
Publicado: (2022)

A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
por: Yoshikawa, Norishige, et al.
Publicado: (2015)

Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo‐controlled, non‐inferiority ARIES HM3 trial
por: Mehra, Mandeep R., et al.
Publicado: (2021)

Laparoscopic Pelvic Lymphadenectomy in the Surgical Treatment of Endometrial Cancer: Results of a Multicenter Study
por: Holub, Zdenek, et al.
Publicado: (2002)

Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomized non‐inferiority trial
por: Walker, Natalie, et al.
Publicado: (2018)

Lymphadenectomy issues in endometrial cancer
por: Konno, Yosuke, et al.
Publicado: (2021)

High-grade uterine corpus-confined endometrial cancer with lymphadenectomy: does adjuvant therapy improve survival?
por: Kılıç, Çiğdem, et al.
Publicado: (2019)

Oral Sedation is Non-Inferior to Intravenous Sedation for Cornea and Glaucoma Surgery: A Randomized Controlled Trial
por: Lee, Hyunjoo J, et al.
Publicado: (2022)

The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression
por: Bryant, Richard J., et al.
Publicado: (2020)

Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2–IIB cervical cancer
por: Chéreau, E, et al.
Publicado: (2012)

The Role of Para-Aortic Lymphadenectomy in the Surgical Staging of Women with Intermediate and High-Risk Endometrial Adenocarcinomas
por: May, Taymaa, et al.
Publicado: (2013)

Systematic versus sentinel-lymph-node-driven axillary-lymph-node dissection in clinically node-negative patients with operable breast cancer. Results of the GF-GS01 randomized trial
por: Roy, P., et al.
Publicado: (2018)

Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers – results from two phase 3, non‐inferiority randomised controlled trials
por: Miwa, H., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kgs78nu171qfubffnshce70btk